Fingerprint
Dive into the research topics of 'Rituximab (anti-CD20) adjunctive therapy for Opsoclonus-Myoclonus syndrome'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Rituximab (anti-CD20) adjunctive therapy for Opsoclonus-Myoclonus syndrome
Michael R. Pranzatelli, Elizabeth D. Tate, Anna L. Travelstead, Jerry Barbosa, Robert A. Bergamini, Lucy Civitello, David N. Franz, Brian S. Greffe, Robin D. Hanson, Craig A. Hurwitz, Karen A. Kalinyak, Howard Kelfer, Yasmin Khakoo, John F. Mantovani, Stacy H. Nicholson, Joann M. Sanders, Stephen Wegner
Research output: Contribution to journal › Article › peer-review
122
Scopus
citations